Medication info
Dualstar Tablet 40/10 mg

Dualstar Tablet 40/10 mg

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
International Pharmaceutical Co., Ltd.
Appearance
A white and light gray double-layered tablet that is oval and biconvex.
Packaging
30 tablets (10 tablets/PTP × 3)
Approval status
Active

MFDS item code 201704545 · Approved 2017.06.21 · Insurance code 643704450

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine). However, if blood pressure is not adequately controlled with an individual component, switching directly to this medicine may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
Child dose
◦ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
International Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or telmisartan. That is, if the existing treatment does not bring the blood pressure to within the normal range, this medication can be taken additionally to help effectively lower and manage blood pressure.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine). However, if blood pressure is not adequately controlled with an individual component, switching directly to this medicine may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.

Child dose

◦ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so pregnant women or those who may become pregnant should not take it. Patients with allergies to the main components of this medication or associated ingredients, severe liver impairment, severe hypotension, or cardiogenic shock should not take this medication. Patients with poor liver function, obstructive biliary disease, heart valve disease, impaired kidney function, elderly individuals, etc., should be particularly cautious when taking this medication, and dose adjustments may be necessary. This medication may commonly cause side effects such as dizziness or peripheral edema, and serious side effects can occur rarely, so any unusual symptoms should prompt immediate consultation with a doctor. Pregnant women should not use this medication, and if pregnancy is confirmed, it should be discontinued as soon as possible and replaced with a safe alternative. As this medication lowers blood pressure, patients with hypotension or insufficient body fluids and salts should stabilize their condition before taking it and should take it according to their doctor's instructions. Patients with poor kidney function should have their potassium and creatinine levels checked regularly during treatment, and caution is necessary when taking potassium supplements or potassium-containing medications due to the risk of hyperkalemia. This medication may interact with other antihypertensive agents or certain medications, so if you are taking other medications, you must inform your doctor or pharmacist. Lactating women are advised not to take this medication because it may pass into breast milk. Children and adolescents under the age of 18 are not recommended to take this medication as its safety and efficacy have not been sufficiently established. In the case of an overdose, low blood pressure, dizziness, and heart problems may occur, so immediate medical attention is required for appropriate treatment. This medication should be kept out of reach of children, in a cool and dry place, and should be taken immediately after opening the packaging.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 100 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hypertrophy
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver injury
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purple spots
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light to pass through. Furthermore, it should be stored at room temperature between 1 to 30 degrees Celsius. Storing it in this manner helps ensure the medication's effectiveness is safely maintained.

Appearance and packaging

Appearance

A white and light gray double-layered tablet that is oval and biconvex.

Package unit

30 tablets (10 tablets/PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.